5-Fluoro-2-Oxindole CAS 56341-41-4 Mimọ>99.0% (LCMS) Sunitinib Malate Agbedemeji Factory

Apejuwe kukuru:

Orukọ Kemikali: 5-Fluoro-2-Oxindole

CAS: 56341-41-4

Mimọ:> 99.0% (LCMS)

Irisi: Imọlẹ Yellow Crystalline Powder

Agbedemeji Sunitinib Malate (CAS: 341031-54-7)

Didara to gaju, iṣelọpọ Iṣowo

E-Mail: alvin@ruifuchem.com

Fi imeeli ranṣẹ si wa

Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Shanghai Ruifu Chemical Co., Ltd jẹ olupilẹṣẹ asiwaju ati olupese ti 5-Fluoro-2-Oxindole (CAS: 56341-41-4) pẹlu didara to gaju, iṣelọpọ iṣowo.Kaabo lati paṣẹ.

Kemikali Properties:

Orukọ Kemikali	5-Fluoro-2-Oxindole
Awọn itumọ ọrọ sisọ	5-Fluorooxindole;5-Fluoro-2-indolinone;5-Fluoroindolin-2-ọkan;5-Fluoro-1,3-Dihydro-indol-2-ọkan
Nọmba CAS	56341-41-4
NỌMBA CAT	RF-PI1543
Iṣura Ipo	Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu
Ilana molikula	C8H6FNO
Òṣuwọn Molikula	151.14
iwuwo	1,311 ± 0,06 g / cm3
Brand	Ruifu Kemikali

Awọn pato:

Nkan	Awọn pato
Ifarahan	Imọlẹ Yellow Crystalline Powder
1 H NMR julọ.Oniranran	Ni ibamu Pẹlu Be
LCMS	Ni ibamu Pẹlu Be
Mimọ / Analysis Ọna	> 99.0% (LCMS)
Ojuami Iyo	143.0 ~ 147.0 ℃
Pipadanu lori Gbigbe	<0.50%
Lapapọ Awọn Aimọ	<1.00%
Igbeyewo Standard	Standard Enterprise
Lilo	Awọn agbedemeji elegbogi;Sunitinib Malate Intermediate

Package & Ibi ipamọ:

Package: Igo, apo apamọwọ Aluminiomu, 25kg / Paali Drum, tabi gẹgẹbi ibeere alabara.

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin.

Awọn anfani:

FAQ:

Ohun elo:

5-Fluoro-2-Oxindole (CAS: 56341-41-4) jẹ lilo akọkọ ni ile-iṣẹ elegbogi bi agbedemeji elegbogi.5-Fluoro-2-Oxindole jẹ agbedemeji ninu iṣelọpọ ti Sunitinib Malate (CAS: 341031-54-7).Sunitinib Malate jẹ iru aramada ti ẹnu olona-ìfọkànsí awọn oogun akàn ti o ni ifọkansi pupọ ati pe o jẹ ti inhibitor tyrosine kinase ti a fojusi pupọ pẹlu orukọ iṣowo rẹ jẹ “Suntent”.O jẹ idagbasoke ni aṣeyọri nipasẹ Ile-iṣẹ Pfizer ati pe o ni ipa ipakokoro-egbo meji.Pẹlupẹlu, o jẹ oogun itọju ailera nikan eyiti o le kọja akoko iwalaaye ọdun 2 ti akàn kidinrin to ti ni ilọsiwaju ati pe o ṣe ipa aringbungbun ni aaye ti carcinoma ati awọn agbegbe itọju tumor stromal gastrointestinal.O wọ ọja ni Kínní 2006 ni Amẹrika.Oogun yii jẹ oogun egboogi-akàn akọkọ eyiti FDA AMẸRIKA fọwọsi ati pe o le ṣe itọju awọn arun meji nigbakanna.